用于1q21+多发性骨髓瘤的枢纽基因和相关药物:通过生物信息学分析确定
Zhiqiang Xu1, Jieni Yu2, Yamei Chen1
1Department of Hematology, ZhongShan Hospital Xiamen University, Xiamen, People's Republic of China.
Hematology (Amsterdam, Netherlands)
|March 4, 2024
概括
1q21+中的遗传变化会影响多发性骨髓瘤 (MM) 的预后. 这项研究确定了像IL6R和DUSP23这样的关键基因,为MM患者带有这种遗传标志物提供了潜在的治疗点.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
背景情况:
- 1q21+遗传变异在多发性骨髓瘤 (MM) 中很常见,并且与预后不佳有关.
- 驱动这种不良影响的特定基因在很大程度上仍未确定.
- 识别这些基因对于开发有针对性的干预措施至关重要.
研究的目的:
- 确定与MM的1q21+变异相关的基因.
- 为了研究这些已识别的基因的预后价值.
- 探索与这些基因相关的潜在药物标.
主要方法:
- 从基因表达综合 (GEO) 数据库下载并分析了GSE2658微阵列数据集.
- 鉴定了差异表达基因 (DEGs),并进行了基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 途径分析.
- 利用权重基因共同表达网络分析 (WGCNA) 和接收器运行特征 (ROC) 曲线来识别和验证枢纽基因.
主要成果:
- 确定了55个与细胞增殖途径相关的差异表达基因 (DEGs).
- 发现NVL,IL6R和DUSP23作为枢纽基因与1q21+和不良MM预后有很强的相关性.
- IL6R和DUSP23显示了与已知的药物之间的潜在相互作用.
结论:
- 鉴定了新的枢纽基因 (NVL,IL6R,DUSP23),涉及1q21+MM的发病和进展.
- 这些基因具有预后价值,并为MM患者提出潜在的治疗策略.
- 需要进一步的研究来阐明MM中这些枢纽基因的精确机制.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


